Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. (ELTP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ELTP · as of Jun 9, 2026
Key Statistics
Explore Elite Pharmaceuticals, Inc. Data
eltp stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
eltp competitorsELTP
ABSCF
AGYTF
BOIRF
BPMUF
FOGCFStock Performance
Full HistoryAbout Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. (ELTP) is a specialized pharmaceutical company focused on the creation and manufacturing of generic medications, as well as oral, controlled-release drug formulations. Its …
what is elite pharmaceuticals, inc. · eltp stock overview · elite pharmaceuticals, inc. company profile · who is elite pharmaceuticals, inc. ceo · eltp OTC · elite pharmaceuticals, inc. headquarters · elite pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Elite Pharmaceuticals, Inc. (ELTP) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Feb 24, 2000. As of the latest trading session, ELTP stock price is $0.37, with a market capitalization of $398.6M. The stock has returned -44.76% over the past 12 months and -24.51% year-to-date.
In fiscal year 2025, Elite Pharmaceuticals, Inc. reported revenue of $84.0M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Elite Pharmaceuticals, Inc. (ELTP) stock price is $0.37. The stock is traded on OTC under the ticker symbol ELTP. The 52-week range is $0.33 – $0.82.